The effect of Mediterranean Diet on the Microbiome and Immune Response in NAFLD Related Liver Disease

SW Sydney0 个研究点目标入组 60 人开始时间: 2020年5月25日最近更新: 2020年6月1日

适应症

试验速览

暂无简介。

•1.Patients with well compensated, Child Pugh A, NAFLD related liver cirrhosis, including those who have undergone resection for HCC.
•2.Patients under the care of the investigators of this study (or their associates) who routinely visit study sites for treatment or care
•3.Patients willing to provide informed consent
•4.Participants must be motivated to eat pre-prepared foods for 12 weeks
•5.Participant is aged between 18-75 years old
•6.Participant is willing and able to provide a stool, urine, blood and oral sample for this study
•7.Participant has not taken any antibiotic medication within the past 3 months
•For control group: Participant is part of the same household than patient recruited and presenting good health

•1.Participant unwilling or unable to provide informed consent
•2.Patient with clinical or biochemical evidence of portal hypertension
•3.Patients with other causes of liver disease, not NAFLD related including alcoholic liver disease and viral hepatitis
•4.Participant who has taken any antibiotic medication within the past 3 months
•5.Participant with diagnosed food allergy or intolerance
•6.Participant is pregnant or breastfeeding
•7.Participant has received nutritional counselling in the previous 3 months
•8.Participants have medical, religious, or cultural dietary restrictions that would preclude their eating a Mediterranean diet

发起方

SW Sydney